Accelerating CAR T Development from Preclinical to Clinical Utilizing Key Biomarker Insights, Upcoming Webinar Hosted by Xtalks
In this free webinar, the featured panelists will discuss the advantages and disadvantages of a variety of preclinical oncology models and how these models and supporting assays can help enable preclinical advancement of CAR T therapies. The presentation will highlight considerations for holistic IND-enabling studies and insights supporting effective clinical design, as well as biomarker strategy implementation to enable more sophisticated clinical studies.
TORONTO, Oct. 12, 2021 /PRNewswire-PRWeb/ -- In this roundtable, expert speakers will focus on the design and approach for preclinical efficacy studies, understanding how these studies fit into the larger safety and toxicology package to bridge into the clinic and inform the implementation of successful biomarker strategies to accelerate development of novel therapeutics including CAR T therapies.
Bring questions to this roundtable where the speakers will discuss topics ranging from:
- Advantages and disadvantages of a variety of preclinical oncology models and approaches
- How these models and supporting assays can enable preclinical advancement
- Key considerations for holistic investigational new drug (IND)-enabling studies and insights supporting effective clinical trial design
- Implementation of biomarker strategies that enable success of complex clinical trials for CAR T therapies
- Evaluation of the types of biomarkers to analyze, key considerations for assay development and the diverse array of biomarker tests currently available and those on the horizon
Register for this webinar to learn how to design preclinical efficacy studies utilizing key biomarkers to support further clinical development of novel CAR T-cell therapeutics.
Join Labcorp Drug Development's Maryland Franklin, PhD, Vice President and Enterprise Head of Cell and Gene Therapy; Akanksha Gupta, PhD, Head, Immunology Biomarker Solution Center; Bruce J. Hamilton, PhD, Drug Development Team Leader, Early Phase Development Solutions; and Sheri Barnes, PhD, Associate Director, Scientific Development, Preclinical Oncology, for the live webinar on Thursday, October 28, 2021 at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Accelerating CAR T Development from Preclinical to Clinical Utilizing Key Biomarker Insights.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, [email protected]
SOURCE Xtalks
Share this article